We are live on ! Find out more
ITCI

Intra-Cellular Therapies Inc.
ITCI

Delisted

ITCI was delisted on the 1st of April, 2025.

Back to rankings

208 hedge funds and large institutions have $3.59B invested in Intra-Cellular Therapies Inc. in 2021 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 57 increasing their positions, 67 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more funds holding in top 10

Funds holding in top 10: 3 → 8 (+5)

143% more first-time investments, than exits

New positions opened: 51 | Existing positions closed: 21

117% more call options, than puts

Call options by funds: $68.2M | Put options by funds: $31.4M

41% more capital invested

Capital invested by funds: $2.55B → $3.59B (+$1.04B)

16% more funds holding

Funds holding: 180 → 208 (+28)

15% less repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 67

Holders
208
Holders Change
+28
Holders Change %
+15.56%
% of All Funds
3.2%
Holding in Top 10
8
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+166.67%
% of All Funds
0.12%
New
51
Increased
57
Reduced
67
Closed
21
Calls
$68.2M
Puts
$31.4M
Net Calls
+$36.7M
Net Calls Change
+$13.4M

Top Buyers

Rank Fund Capital Flow
1
PAMS
Pictet Asset Management (Switzerland)
Switzerland
+$61.1M
2
GKIM
GW&K Investment Management
Massachusetts
+$15.7M
3
Deutsche Bank
Deutsche Bank
Germany
+$13.3M
4
Two Sigma Investments
Two Sigma Investments
New York
+$11.7M
5
Norges Bank
Norges Bank
Norway
+$9.48M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$17.9M
2
TCM
TimesSquare Capital Management
New York
-$15.7M
3
CS
Candriam SCA
Luxembourg
-$15.5M
4
Goldman Sachs
Goldman Sachs
New York
-$14.8M
5
Franklin Resources
Franklin Resources
California
-$11.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
EI
201
Ellevest Inc
New York
$1K -$252 -6 -27%
BIA
202
Bell Investment Advisors
California
$1K – – –
VCM
203
Versant Capital Management
Arizona
$1K – – –
Northwestern Mutual Wealth Management
204
Northwestern Mutual Wealth Management
Wisconsin
$1K +$420 +10 New
MPWT
205
MassMutual Private Wealth & Trust
Connecticut
$1K +$504 +12 New
C
206
Covestor
United Kingdom
$1K +$630 +15 New
IC
207
Ikarian Capital
Texas
– -$7.89M -211,670 Closed
PVI
208
Pura Vida Investments
New York
– -$1.95M -52,213 Closed
HF
209
HRT Financial
New York
– -$1.46M -39,041 Closed
Lazard Asset Management
210
Lazard Asset Management
New York
– -$1.18M -31,525 Closed
DTL
211
Dynamic Technology Lab
Singapore
– -$812K -21,780 Closed
BFM
212
Boothbay Fund Management
New York
– -$740K -19,851 Closed
Tudor Investment Corp
213
Tudor Investment Corp
Connecticut
– -$696K -18,678 Closed
HT
214
HAP Trading
New York
– -$607K -14,460 Closed
OMC
215
Old Mission Capital
Illinois
– -$452K -12,118 Closed
LP
216
LMR Partners
United Kingdom
– -$447K -12,000 Closed
WG
217
Winton Group
United Kingdom
– -$424K -11,369 Closed
PAM
218
Premier Asset Management
Illinois
– -$377K -10,119 Closed
MPCG
219
Matrix Private Capital Group
New York
– -$291K -7,800 Closed
ECM
220
ExodusPoint Capital Management
New York
– -$256K -6,859 Closed
SIG
221
Sargent Investment Group
Maryland
– -$221K -5,923 Closed
CC
222
Centiva Capital
New York
– -$207K -5,561 Closed
AA
223
AlphaCentric Advisors
Puerto Rico
– -$149K -4,000 Closed
PCM
224
Penserra Capital Management
California
– -$69K -1,860 Closed
GRP
225
Global Retirement Partners
California
– -$32K -863 Closed
6 7 8
9
10

ITCI Hedge Fund Activity: Q4 2021 in Review

208 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Intra-Cellular Therapies Inc. (ITCI) for Q4 2021, worth a combined $3.59B — up 41% from $2.55B a quarter earlier.

Buyers outnumbered sellers: 51 funds opened new ITCI positions and 21 closed out — a net gain of 30 holders — while 57 added to existing stakes and 67 trimmed.

The largest buyer was Pictet Asset Management (Switzerland), opening a new position worth an estimated $61.1M. The largest seller was Citadel Advisors, cutting an estimated $17.9M.

  • 208 institutional investors held Intra-Cellular Therapies Inc. (ITCI) as of Q4 2021, up from 180 in Q3 2021.
  • Funds reported $3.59B of Intra-Cellular Therapies Inc. stock for Q4 2021, up 41% quarter-over-quarter.
  • 51 funds opened new Intra-Cellular Therapies Inc. positions in Q4 2021 and 21 closed out, a net change of +30 holders.
  • The largest Intra-Cellular Therapies Inc. buyer in Q4 2021 was Pictet Asset Management (Switzerland), an estimated $61.1M added.
  • The largest Intra-Cellular Therapies Inc. seller in Q4 2021 was Citadel Advisors, an estimated $17.9M sold.

Based on aggregated 13F filings for Q4 2021.